Bausch Health reported strong Q4 results with a 6.2% Y/Y revenue increase and positive net income, driving a 10% stock rally.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2024 financial results and provided a corporate update.

Milwaukee Bucks center Bobby Portis has been suspended by the NBA for 25 games, ESPN's Shams Charania reported on Thursday ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Thank goodness for pharmacies around the country taking matters into their own hands. According to the BioPharma Dive website, Trump’s move—or should I say Elon Musk’s move—to drastically reduce the ...

On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...

The NBA is suspending big man Bobby Portis Jr. for 25 games for violating the terms of the NBA/NBPA Anti-Drug Program, the ...

Galapagos shifts to CAR-T therapy with GLPG5101, targeting pivotal trials by 2026. Click here to find out why I rate GLPG ...

Milwaukee Bucks forward Bobby Portis Jr. is facing a 25-game suspension for violating the NBA's anti-drug policy, according ...

Milwaukee Bucks forward Bobby Portis Jr. has been suspended for 25 games after he violated the NBA’s anti-drug policy, the ...